Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter
about
Pregnenolone rescues schizophrenia-like behavior in dopamine transporter knockout mice.Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophreniaN-3 Polyunsaturated Fatty Acids through the Lifespan: Implication for PsychopathologyGenome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorderAssociation of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorderAMPAKINE enhancement of social interaction in the BTBR mouse model of autismNpas4: a neuronal transcription factor with a key role in social and cognitive functions relevant to developmental disorders.Glycogen synthase kinase-3β inhibition in the medial prefrontal cortex mediates paradoxical amphetamine action in a mouse model of ADHD.Pregnenolone sulfate normalizes schizophrenia-like behaviors in dopamine transporter knockout mice through the AKT/GSK3β pathway.Disruption of dopamine neuron activity pattern regulation through selective expression of a human KCNN3 mutation.Abnormal behaviors and developmental disorder of hippocampus in zinc finger protein 521 (ZFP521) mutant miceGABA transporter-1 deficiency confers schizophrenia-like behavioral phenotypes.Annual Research Review: Transgenic mouse models of childhood-onset psychiatric disorders.Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspectsGeneration and characterization of conditional heparin-binding EGF-like growth factor knockout mice.NMDA receptor-deficient mice display sexual dimorphism in the onset and severity of behavioural abnormalities.Persistent hyperdopaminergia decreases the peak frequency of hippocampal theta oscillations during quiet waking and REM sleepDopamine transporters govern diurnal variation in extracellular dopamine tone.Diacylglycerol kinase β knockout mice exhibit attention-deficit behavior and an abnormal response on methylphenidate-induced hyperactivityInvolvement of 5-HT receptors in the development and expression of methamphetamine-induced behavioral sensitization: 5-HT receptor channel and binding study.The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice.The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders.Gβ5-RGS complexes are gatekeepers of hyperactivity involved in control of multiple neurotransmitter systems.Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder?Magnetic resonance imaging and spectroscopy in a mouse model of schizophrenia.Marine Ο-3 polyunsaturated fatty acids induce sex-specific changes in reinforcer-controlled behaviour and neurotransmitter metabolism in a spontaneously hypertensive rat model of ADHD.Immature dentate gyrus: an endophenotype of neuropsychiatric disorders.Dopamine transporter mutant animals: a translational perspective.Transgenic mouse models for ADHD.D1 dopamine receptor coupling to PLCβ regulates forward locomotion in mice.GSK-3β activity and hyperdopamine-dependent behaviorsGenetics of attention-deficit/hyperactivity disorder: current findings and future directions.Perinatal 6-Hydroxydopamine Modeling of ADHD.Attention deficit-hyperactivity disorder is associated with reduced blood pressure and serum vitamin D levels: results from the nationwide German Health Interview and Examination Survey for Children and Adolescents (KiGGS).Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders.Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice.The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice.Follow-up of genetic linkage findings on chromosome 16p13: evidence of association of N-methyl-D aspartate glutamate receptor 2A gene polymorphism with ADHD.Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background.
P2860
Q21133801-75A98BDF-8D54-41B0-8330-D39D587B73FFQ24678573-1344F7DB-DBCA-472B-9409-0F8731B02F7FQ28072641-CA7EF571-4657-4E45-A972-17A10D6AA608Q28254567-7639C6F7-0582-43CC-866A-AA19E1ADB6CAQ28266092-5FFC62B4-5BE8-4E44-9CE2-74E4B5F19656Q28388762-2A42BA62-B83D-4150-B111-57A33A0418BBQ28389182-708358C2-4CF4-4AAF-B3CB-25D27C038E37Q30414710-E39E40D3-03C5-41F8-9325-991AD2BB1C00Q30416840-381702E6-B423-4209-A1FD-81AF2936A4ACQ30425716-333D4089-78E7-4B59-8743-9D5070F912B9Q30440967-E627EEC8-11F7-4117-9C33-C2A9146C50A3Q30451228-5F470BF0-A117-4D73-8522-3808036C954EQ30469044-2A11AA0E-197D-48EC-82AC-F8ED2F40C545Q30476813-4145F3A7-7200-467F-87E1-7A18A7F010C5Q30485976-1A3F5C73-39CA-439E-9B3B-8F0A6869F2BEQ33359313-12F5F0EE-07B6-47D3-94F5-B8A2A452DD07Q33432811-E095A2B7-EDEF-4EA5-B45B-9E900C59C553Q33853949-89EC690C-492D-4346-8D76-F42AD7095B74Q34271154-4974C152-4253-433A-8618-C357D8D65F49Q34561864-DE552994-FA26-4D32-8F97-0184C3691577Q35054681-61A510E6-742F-4C11-807F-9E461B1C638DQ35157705-310F728D-143B-4DAA-B2DE-5542FB256065Q35589965-FF08CAA9-A822-4991-83E7-D94AFD7CAC10Q35678190-8F852DA5-0E04-45D3-B4DA-51031D2449B9Q36517227-51CAB396-6AEE-440F-8A81-E470AA6EB81CQ36607423-C9214E21-D43C-40E3-825B-ED7FD1BB9A58Q36614190-6C2C5157-499C-48E8-921E-E14F2EDB1821Q36960113-A49C0C62-C032-4A71-BF8A-2E89D7CE5E47Q36992394-3E6E3412-D998-4509-8B93-D0B3B7888732Q37203801-3B3596B0-2252-4CA5-A863-E6FF57472131Q37309537-E17F4505-7499-425E-A856-21E279B19012Q37781424-31ED835F-307F-4EB8-85C4-8F758C570A29Q38094814-501E71F1-3931-4AE1-A4E4-D6B24E328305Q38609428-520D04B5-91C5-4521-8AF7-EA5D9853677DQ39752543-BAD176E5-7228-4F8D-BEE6-41D0BFDE3D82Q41700939-5A1DCB6C-E314-47A1-8FB6-5718A63696ADQ42500923-EADE7E0F-8B37-4A92-AE86-6899BB6D983CQ44645827-23D1BDA5-9760-4787-BACB-938831911884Q44765961-E0C4A325-C56E-4A15-A709-7D477FAC63A4Q44971583-420B0BAC-8143-4A54-8B62-8E2E54F6EC35
P2860
Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter
@ast
Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter
@en
Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter
@nl
type
label
Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter
@ast
Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter
@en
Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter
@nl
prefLabel
Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter
@ast
Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter
@en
Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter
@nl
P2860
P3181
P356
P1476
Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter
@en
P2093
P2860
P304
11047-11054
P3181
P356
10.1073/PNAS.191353298
P407
P577
2001-09-01T00:00:00Z